Intuitive Surgical Inc banner

Intuitive Surgical Inc
NASDAQ:ISRG

Watchlist Manager
Intuitive Surgical Inc Logo
Intuitive Surgical Inc
NASDAQ:ISRG
Watchlist
Price: 478.82 USD -0.99% Market Closed
Market Cap: $170.1B

EV/EBIT

55.5
Current
19%
Cheaper
vs 3-y average of 68.7

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
55.5
=
Enterprise Value
$172.4B
/
EBIT
$3B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
55.5
=
Enterprise Value
$172.4B
/
EBIT
$3B

Valuation Scenarios

Intuitive Surgical Inc is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (68.7), the stock would be worth $592.75 (24% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-65%
Maximum Upside
+24%
Average Downside
22%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 55.5 $478.82
0%
3-Year Average 68.7 $592.75
+24%
5-Year Average 66 $569.54
+19%
Industry Average 19.2 $166.09
-65%
Country Average 19.6 $169.31
-65%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
$172.4B
/
Jan 2026
$3B
=
55.5
Current
$172.4B
/
Dec 2026
$4.4B
=
39.4
Forward
$172.4B
/
Dec 2027
$5B
=
34.2
Forward
$172.4B
/
Dec 2028
$5.8B
=
29.7
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
US
Intuitive Surgical Inc
NASDAQ:ISRG
170B USD 55.5 59.5
US
Abbott Laboratories
NYSE:ABT
160.6B USD 19.1 25.6
US
Stryker Corp
NYSE:SYK
126.1B USD 24 38.8
IE
Medtronic PLC
NYSE:MDT
107.5B USD 18.9 23.3
US
Boston Scientific Corp
NYSE:BSX
97.4B USD 26.6 33.6
DE
Siemens Healthineers AG
XETRA:SHL
40.6B EUR 15 18.9
US
Edwards Lifesciences Corp
NYSE:EW
46.3B USD 25.7 43.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.7B USD 33 42.2
US
Becton Dickinson and Co
NYSE:BDX
44.1B USD 16.8 25.1
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
31.9B USD 13.4 15.3
US
Resmed Inc
NYSE:RMD
32B USD 16.8 21.5

Market Distribution

Higher than 89% of companies in the United States of America
Percentile
89th
Based on 8 638 companies
89th percentile
55.5
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

Intuitive Surgical Inc
Glance View

In the rapidly evolving landscape of medical technology, Intuitive Surgical Inc. stands as a pioneer, revolutionizing the way surgeries are performed through its groundbreaking robotic systems. Founded in 1995, the company has set the benchmark for minimally invasive surgery with its flagship product, the da Vinci Surgical System. This sophisticated platform integrates advanced robotics, 3D visualization, and intuitive controls to enable surgeons to perform intricate procedures with precision and control that far surpass conventional methods. By enhancing the dexterity of the human hand and allowing for remarkably steady movements, the system reduces the physical strain on surgeons while improving patient outcomes in terms of reduced recovery time, minimized scarring, and lower risk of infection. Intuitive Surgical’s business model is both innovative and practical, capitalizing on a combination of product sales, ongoing service agreements, and instrument and accessory sales. Initially, hospitals and medical centers invest significantly in acquiring the da Vinci Systems, providing Intuitive with substantial capital inflows. However, the true genius of the company's revenue model lies in its ecosystem approach; ongoing revenue is generated through the sale of disposable instruments and components needed for each surgery. Additionally, the firm offers extensive maintenance and support services, ensuring that healthcare providers maximize their return on investment while maintaining optimal performance of their surgical systems. This balanced model creates a consistent and reliable income stream, enhancing the company's financial stability and enabling it to invest continually in research and development.

ISRG Intrinsic Value
187.26 USD
Overvaluation 61%
Intrinsic Value
Price $478.82
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett